No Data
No Data
Phio Pharmaceuticals Has Entered Into Definitive Agreements For The Purchase And Sale Of An Aggregate Of 240K Shares At A Price Of $2.00 Per Share In A Registered Direct Offering
12 Health Care Stocks Moving In Monday's Pre-Market Session
Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Wall Street Set to Open Lower Monday as Investors Look for a Year-End Rally
Investors Look to Reverse Last Week's Slide as US Futures Mixed Monday Pre-Bell
Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket
No Data